Rules for the use of reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

MeSH terms

• Administration, Oral
• Anticoagulants / therapeutic use
• Atrial Fibrillation* / complications
• Atrial Fibrillation* / drug therapy
• Automobiles
• Humans
• Poland
• Stroke* / etiology
• Thromboembolism* / drug therapy
• Thromboembolism* / etiology
• Thromboembolism* / prevention & control